Showing results (211-220 of 288) with videos related to
Sort By:
Pageof 29
The Biochemical Journal|May 24, 2008
Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processingYueming Qian, Sanjay Banerjee, Craig E Grossman, et al.The Biochemical Journal|April 30, 2004
Deletion of Ser-171 causes inactivation, proteasome-mediated degradation and complete deficiency of human transaldolaseCraig E Grossman, Brian Niland, Christina Stancato, et al.Autoimmunity|February 8, 2017
Alterations in B cell development, CDR-H3 repertoire and dsDNA-binding antibody production among C57BL/6 ΔD-iD mice congenic for the lupus susceptibility loci sle1, sle2 or sle3Mohamed Khass, Robert L Schelonka, Cun Ren Liu, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2013
Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosusZhi-Wei Lai, Rebecca Borsuk, Ashwini Shadakshari, et al.American Journal of Physiology. Renal Physiology|February 26, 2016
Quercitrin ameliorates the development of systemic lupus erythematosus-like disease in a chronic graft-versus-host murine modelWei Li, Hu Li, Mu Zhang, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|November 21, 2008
The publishing game: reflections of an editorial teamJames M Crawford, Catherine M Ketcham, Raul Braylan, et al.Frontiers in Immunology|April 21, 2017
B Cell Tolerance to Deiminated Histones in BALB/c, C57BL/6, and Autoimmune-Prone Mouse StrainsNishant Dwivedi, Annica Hedberg, Ying Yi Zheng, et al.RMD Open|October 26, 2022
Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trialHuijing Wang, Ting Li, Fangfang Sun, et al.International Journal of Molecular Sciences|November 13, 2025
Potassium-Hydroxide-Based Extraction of Nicotinamide Adenine Dinucleotides from Biological Samples Offers Accurate Assessment of Intracellular Redox StatusTamas Faludi, Daniel Krakko, Jessica Nolan, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradationDavid R Fernandez, Tiffany Telarico, Eduardo Bonilla, et al.Pageof 29